The Long Road Narrative

 | Nov 17, 2020 12:22PM ET

State Of The Market: Executive Summary

I know what you're thinking. If the stock market is looking ahead to better days, why were the stocks falling this morning?

From my seat, there appears to be three driving forces on this fine Tuesday morning. First, and perhaps most important, is the report on retail sales. But before we dive into the numbers, it is important to remember that consumers account for something like 70% of all economic activity in the United States. And with the all-important holiday shopping season coming fast, how the consumer is feeling about spending money these days is an important input to the market outlook equation.

While I won't bore you with too many data points, the Commerce Department reported this morning that retail sales rose by 0.3% in October and the numbers for September were revised lower to 1.6%. There are a couple key points here. First, the October number was below the consensus estimate of 0.5%. So, we can put that in the "miss" or disappointing column. Next, September was revised lower by 0.3% (from 1.9%), which, when combined with the October reading, means that retail sales have flat-lined recently. And the bottom line is this is not a desired result heading into the holiday shopping period.

It looks like the breathtaking, exponential spike in coronavirus cases, hospitalizations and deaths is weighing on the consumer's collective psyche. Now, factor in the concern about additional lockdowns and layoffs, and well, Mr. and Mrs. John Q. Public can't be blamed for being a little cautious here.

I will argue that the next driver to today's action is profit-taking from the explosive rotation trade. Make no mistake about it; I abhor the "profit-taking" excuse the media tends to lazily apply whenever stocks are lower. But I think the idea of taking some profits after an impressive surge in the small caps/cyclicals/value trade makes some sense. Especially when you consider that algos tend to overdue just about everything on an intraday basis. So, with reports showing that value has outperformed growth by a record margin lately, it's not surprising that the fast-money types might want to cash in some chips here.

And finally, there is what I'll call "The Long Road" narrative. To be sure, the Pfizer/BioNTech and Moderna (NASDAQ:MRNA) news is wonderful and should give us all hope for the future. However, getting enough of the world's population vaccinated with a vaccine that must be (a) stored at incredibly low temperatures and (b) administered twice to every person, is likely to prove challenging from a logistical standpoint. Especially when a disturbing percentage of Americans object vehemently to even wearing a darn mask!

So, I will opine that the "recovery trade" is unlikely to move in a straight line. Yes, I'd love to be wrong here as nothing makes me happier than a runaway bull train. But, my guess is this theme will be second-guessed from time to time and as such, the road back to "normal" is likely to be more than a little bumpy.

Get The News You Want
Read market moving news with a personalized feed of stocks you care about.
Get The App

The State Of Trend Indicators

It is said that sometimes less is more. So, let me simply say that the Trend Board is in pretty good shape here. Advantage bulls.